References
- Aboody KS, Brown A, Rainov NG, et al. Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas. Proc Natl Acad Sci USA 2002; 97: 12846–12851
- Mahmood A, Lu D, Chopp M, et al. Intravenous administration of marrow stromal cells (MSCs) increases the expression of growth factors in rat brain after traumatic brain injury. J Neurotrauma 2004; 21: 33–39
- Kurozumi K, Nakamura K, Tamiya T, et al. Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol Ther 2005; 11: 96–104
- Ehtesham M, Kabos P, Kabosova A, et al. The use of interleukin12-secreting neural stem cells for the treatment of intracranial glioma. Cancer Res 2002; 62: 5657–5663
- Ehtesham M, Yuan X, Kabos, et al. Glioma tropic neural stem cells consist of astrocytic precursors and their migratory capacity is mediated by CXCR4. Neoplasia 2004; 6: 287–293
- Namba H, Tagawa M, Iwadate Y, et al. Bystander effect-mediatedtherapy of experimental brain tumor by genetically engineered tumor cells. Hum Gene Ther 1998; 9: 5–11
- Li S, Tokuyama T, Yamamoto J, et al. Bystander effect-mediatedgene therapy of gliomas using genetically engineered neural stem cells. Cancer Gene Ther 2005; 2: 600–607
- Soling A, Theiss C, Jungmichel S, et al. A dual function fusion protein of Herpes simplex virus type 1 thymidine kinase and firefly luciferase for noninvasive in vivo imaging of gene therapy in malignant glioma. Genet Vaccines Ther 2004; 2: 7
- Hamada H, Kobune M, Nakamura K, et al. Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy. Cancer Sci 2005; 96: 149–156
- Nakamizo A, Marini F, Amano T, et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 2005; 65: 3307–3318
- Nakamura K, Ito Y, Kawano Y, et al. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther 2004; 11: 1155–1164
- Okamoto T, Aoyama T, Nakayama T, et al. Clonal heterogeneity in differentiation potential of immortalized human mesenchymal stem cells. Biochem Biophys Res Commun 2002; 295: 354–361
- Kazuki Y, Hoshiya H, Kai Y, et al. Correction of a genetic defect in multipotent germline stem cells using a human artificial chromosome. Gene Ther 2008; 15: 617–624
- Katoh M, Ayabe F, Norikane S, et al. Construction of a novel human artificial chromosome vector for gene delivery. Biochem Biophys Res Commun 2004; 321: 280–290
- Ren X, Katoh M, Hoshiya H, et al. A novel human artificial chromosome vector provides effective cell lineage-specific trans-gene expression in human mesenchymal stem cells. Stem Cells 2005; 23: 1608–1616
- Ren X, Tahimic CG, Katoh M, et al. Human artificial chromo-some vectors meet stem cells: New prospects for gene delivery. Stem Cell Rev 2006; 2: 43–50
- Mageed AS, Pietryga DW, DeHeer DH, et al. Isolation of large numbers of mesenchymal stem cells from the washings of bone marrow collection bags: Characterization of fresh mesenchymal stem cells. Transplantation 2007; 83: 1019–1026
- Bühring Hi, Battula VL, Treml S, et al. Novel markers for the prospective isolation of human MSC. Ann NY Acad Sci 2007; 1106: 262–267
- Satake K, Lou J, Lenke LG, et al. Migration of mesenchymal stem cells through cerebrospinal fluid into injured spinal cord tissue. Spine 2004; 29: 1971–1979
- Wennersten A, Meier X, Holmin S, et al. Proliferation, migration, and differentiation of human neural stem/progenitor cells after transplantation into a rat model of traumatic brain injury. J Neurosurg 2004; 100: 88–96
- Schmidt NO, Przylecki W, Yang W, et al. Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor. Neoplasia 2005; 7: 623–639
- Shah K, Bureau E, Kim DE, et al. Glioma therapy and real-time imaging of neural precursor cell migration and tumor regression. Ann Neurol 2005; 57: 34–41
- Shitara S, Kakeda M, Nagata K, et al. Telomerase-mediated life-span extension of human primary fibroblasts by human artificial chromosome (HAC) vector. Biochem Biophys Res Commun 2008; 369: 807–811
- Rainov NG. A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum Gene Ther 2000; 11: 2389–2401.